Source: International Congress 2018 – Biomarkers of COPD and asthma-COPD overlap syndrome (ACOS)
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
S. Matthes (Munich, Germany), J. Stadler (Munich, Germany), J. Barton (Munich, Germany), H. Villena-Hermoza (Munich, Germany), M. Frankenberger (Munich, Germany), N. Kneidinger (Munich, Germany), K. Milger (Munich, Germany), P. Probst (Munich, Germany), G. Leuschner (Munich, Germany), D. Muncker (Munich, Germany), P. Arnold (Munich, Germany), A. Koch (Munich, Germany), J. Behr (Munich, Germany), C. Neurohr (Stuttgart, Germany). Identifying asthma features in severe COPD. 5472

Member's Comments

No comment yet.

Related content which might interest you: Distribution of biomarkers in severe asthma and severe uncontrolled asthma Source: Virtual Congress 2021 – Pearls in asthma and respiratory burden research Year: 2021 Defining the clinical clusters of severe asthma within UBIOPRED Source: International Congress 2015 – Fingerprinting severe asthma Year: 2015 Genetic comparison between severe persistent asthma and COPD Source: Eur Respir J 2003; 22: Suppl. 45, 81s Year: 2003 COPD patients with asthma, characteristics and risk of exacerbations Source: International Congress 2019 – Multimorbidity in airway diseases and appropriate inhaled corticosteroid use in COPD Year: 2019 OSA phenotypes in asthma and COPD Source: International Congress 2018 – From continuous positive airway pressure (CPAP) and adherence to CPAP to asthma-COPD overlap syndrome (ACOS) Year: 2018 Severe outcomes of COVID-19 among patients with COPD and asthma Source: ERJ Open Res, 7 (1) 00594-2020; 10.1183/23120541.00594-2020 Year: 2021 The bronchitic phenotype is associated with frequent exacerbations in COPD irrespective of chronic bacterial airway infection Source: Annual Congress 2013 –Guidelines and exacerbations Year: 2013 Management of difficult-to-treat severe asthma Source: Eur Respir Mon 2011; 51: 282-296 Year: 2011 Markers of T2-inflammation in patients with severe asthma and concomitant COPD Source: Virtual Congress 2020 – News on clinical evaluation of bronchiectasis, cough and inflammatory disease Year: 2020 Difficulty in management of COPD exacerbation: Is this chronic exacerbation or difficult COPD: “A specific phenotype?” Source: Annual Congress 2013 –COPD biomarkers Year: 2013 Incidence of COPD and asthma overlap Source: Annual Congress 2009 - Asthma assessment and original therapeutic approaches Year: 2009 Clinically relevant subgroups in COPD and asthma Source: Eur Respir Rev 2015; 24: 283-298 Year: 2015 Targeting traits in asthma and COPD Source: Virtual Congress 2021 – Pharmacology of lung immune responses: which pathways to target! Year: 2021 Acute exacerbation phenotypes of asthma and COPD: impact on clinical outcomes Source: Virtual Congress 2021 – Biomarkers to phenotype asthma: prediction of exacerbations Year: 2021 Are comorbidities related to frequent severe exacerbations of COPD? Source: International Congress 2019 – Phenotypes and comorbidities of airway diseases Year: 2019 The asthma–COPD overlap syndrome Source: Eur Respir Monogr 2015; 69: 85-95 Year: 2015 Assessing severe asthma Source: Eur Respir J 2016; 48: 611-613 Year: 2016